Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.
about
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model VerificationDevelopment of a physiologically-based pharmacokinetic model of the rat central nervous system.Reliability of In Vitro and In Vivo Methods for Predicting the Effect of P-Glycoprotein on the Delivery of Antidepressants to the Brain.An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1.Delivery of siRNA silencing P-gp in peptide-functionalized nanoparticles causes efflux modulation at the blood-brain barrier.
P2860
Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Challenges of using in vitro d ...... ux in the blood-brain barrier.
@ast
Challenges of using in vitro d ...... ux in the blood-brain barrier.
@en
type
label
Challenges of using in vitro d ...... ux in the blood-brain barrier.
@ast
Challenges of using in vitro d ...... ux in the blood-brain barrier.
@en
prefLabel
Challenges of using in vitro d ...... ux in the blood-brain barrier.
@ast
Challenges of using in vitro d ...... ux in the blood-brain barrier.
@en
P2093
P2860
P1476
Challenges of using in vitro d ...... ux in the blood-brain barrier.
@en
P2093
Arto Urtti
Hanna Kortejärvi
Heidi Kidron
Kati-Sisko Vellonen
Marjo Yliperttula
Noora Sjöstedt
P2860
P356
10.1007/S11095-013-1124-2
P577
2014-01-01T00:00:00Z